LIFEVANTAGE CORP Selling, General and Administrative Expense
LIFEVANTAGE CORP (LFVN) reported Selling, General and Administrative Expense of $58.42 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-27
- LIFEVANTAGE CORP selling, general and administrative expense for the quarter ending 2026-06-30 was $13.87M, a 25.73% decline year-over-year.
- LIFEVANTAGE CORP selling, general and administrative expense for the quarter ending 2026-03-31 was $13.87M, a 18.76% decline year-over-year.
- LIFEVANTAGE CORP selling, general and administrative expense for the quarter ending 2025-12-31 was $15.83M, a 14.97% decline year-over-year.
- LIFEVANTAGE CORP selling, general and administrative expense for the quarter ending 2025-09-30 was $14.85M, a 0.03% increase year-over-year.
- LIFEVANTAGE CORP selling, general and administrative expense for fiscal 2026 was $58.42M, a 15.59% decline from fiscal 2025.
- LIFEVANTAGE CORP selling, general and administrative expense for fiscal 2025 was $69.21M, a 1.07% increase from fiscal 2024.
- LIFEVANTAGE CORP selling, general and administrative expense for fiscal 2024 was $68.47M, a 3.65% decline from fiscal 2023.
- LIFEVANTAGE CORP selling, general and administrative expense for fiscal 2023 was $71.06M, a 12.05% increase from fiscal 2022.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $27.74M derived: sum of 2 quarters · filed 2026-08-27 | $43.56M derived: sum of 3 quarters · filed 2026-08-27 | $58.42M 10-K · filed 2026-08-27 |
| 2026-03-31 | $13.87M 10-Q · filed 2026-05-06 | $29.69M derived: sum of 2 quarters · filed 2026-05-06 | $44.55M 10-Q · filed 2026-05-06 | $63.22M derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-12-31 | $15.83M 10-Q · filed 2026-02-04 | $30.68M 10-Q · filed 2026-02-04 | $49.36M derived: sum of 3 quarters · filed 2026-08-27 | $66.42M derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-09-30 | $14.85M 10-Q · filed 2025-11-04 | $33.53M derived: sum of 2 quarters · filed 2026-08-27 | $50.60M derived: sum of 3 quarters · filed 2026-08-27 | $69.21M derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-06-30 | $18.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $35.74M derived: sum of 2 quarters · filed 2026-08-27 | $54.36M derived: sum of 3 quarters · filed 2026-08-27 | $69.21M 10-K · filed 2026-08-27 |
| 2025-03-31 | $17.07M 10-Q · filed 2026-05-06 | $35.68M derived: sum of 2 quarters · filed 2026-05-06 | $50.53M 10-Q · filed 2026-05-06 | $64.55M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $18.61M 10-Q · filed 2026-02-04 | $33.46M 10-Q · filed 2026-02-04 | $47.48M derived: sum of 3 quarters · filed 2026-02-04 | $63.91M derived: sum of 4 quarters · filed 2026-02-04 |
| 2024-09-30 | $14.85M 10-Q · filed 2025-11-04 | $28.87M derived: sum of 2 quarters · filed 2025-11-04 | $45.29M derived: sum of 3 quarters · filed 2025-11-04 | $65.36M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $14.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-04 | $30.45M derived: sum of 2 quarters · filed 2025-09-04 | $50.51M derived: sum of 3 quarters · filed 2025-09-04 | $68.47M 10-K · filed 2025-09-04 |
| 2024-03-31 | $16.43M 10-Q · filed 2025-05-06 | $36.49M derived: sum of 2 quarters · filed 2025-05-06 | $54.45M 10-Q · filed 2025-05-06 | $71.50M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $20.07M 10-Q · filed 2025-02-05 | $38.03M 10-Q · filed 2025-02-05 | $55.07M derived: sum of 3 quarters · filed 2025-02-05 | $72.78M derived: sum of 4 quarters · filed 2025-02-05 |
| 2023-09-30 | $17.96M 10-Q · filed 2024-10-29 | $35.01M derived: sum of 2 quarters · filed 2024-10-29 | $52.72M derived: sum of 3 quarters · filed 2024-10-29 | $72.30M derived: sum of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | $17.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | $34.76M derived: sum of 2 quarters · filed 2024-08-28 | $54.34M derived: sum of 3 quarters · filed 2024-08-28 | $71.06M 10-K · filed 2024-08-28 |
| 2023-03-31 | $17.71M 10-Q · filed 2024-05-02 | $37.29M derived: sum of 2 quarters · filed 2024-05-02 | $54.02M 10-Q · filed 2024-05-02 | $69.63M derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $19.58M 10-Q · filed 2024-01-30 | $36.31M 10-Q · filed 2024-01-30 | $51.92M derived: sum of 3 quarters · filed 2024-01-30 | $67.24M derived: sum of 4 quarters · filed 2024-01-30 |
| 2022-09-30 | $16.73M 10-Q · filed 2023-11-09 | $32.34M derived: sum of 2 quarters · filed 2023-11-09 | $47.66M derived: sum of 3 quarters · filed 2023-11-09 | $65.08M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $15.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-28 | $30.93M derived: sum of 2 quarters · filed 2023-08-28 | $48.35M derived: sum of 3 quarters · filed 2023-08-28 | $63.42M 10-K · filed 2023-08-28 |
| 2022-03-31 | $15.32M 10-Q · filed 2023-05-04 | $32.74M derived: sum of 2 quarters · filed 2023-05-04 | $47.81M 10-Q · filed 2023-05-04 | $60.62M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $17.42M 10-Q · filed 2023-02-02 | $32.50M 10-Q · filed 2023-02-02 | $45.31M derived: sum of 3 quarters · filed 2023-02-02 | $60.82M derived: sum of 4 quarters · filed 2023-02-02 |
| 2021-09-30 | $15.08M 10-Q · filed 2022-11-02 | $27.89M derived: sum of 2 quarters · filed 2022-11-02 | $43.40M derived: sum of 3 quarters · filed 2022-11-02 | $59.62M derived: sum of 4 quarters · filed 2022-11-02 |
| 2021-06-30 | $12.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-23 | $28.32M derived: sum of 2 quarters · filed 2022-08-23 | $44.54M derived: sum of 3 quarters · filed 2022-08-23 | $60.84M 10-K · filed 2022-08-23 |
| 2021-03-31 | $15.51M 10-Q · filed 2022-05-03 | $31.73M derived: sum of 2 quarters · filed 2022-05-03 | $48.03M 10-Q · filed 2022-05-03 | $62.84M derived: sum of 4 quarters · filed 2022-08-23 |
| 2020-12-31 | $16.22M 10-Q · filed 2022-02-01 | $32.52M 10-Q · filed 2022-02-01 | $47.33M derived: sum of 3 quarters · filed 2022-08-23 | $64.61M derived: sum of 4 quarters · filed 2022-08-23 |
| 2020-09-30 | $16.30M 10-Q · filed 2021-11-04 | $31.11M derived: sum of 2 quarters · filed 2022-08-23 | $48.40M derived: sum of 3 quarters · filed 2022-08-23 | $66.53M derived: sum of 4 quarters · filed 2022-08-23 |
| 2020-06-30 | $14.82M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-23 | $32.10M derived: sum of 2 quarters · filed 2022-08-23 | $50.23M derived: sum of 3 quarters · filed 2022-08-23 | $67.91M 10-K · filed 2022-08-23 |
| 2020-03-31 | $17.28M 10-Q · filed 2021-04-29 | $35.41M derived: sum of 2 quarters · filed 2021-04-29 | $53.10M 10-Q · filed 2021-04-29 | $68.44M derived: sum of 4 quarters · filed 2021-08-19 |
| 2019-12-31 | $18.13M 10-Q · filed 2021-02-02 | $35.82M 10-Q · filed 2021-02-02 | $51.16M derived: sum of 3 quarters · filed 2021-08-19 | $68.45M derived: sum of 4 quarters · filed 2021-08-19 |
| 2019-09-30 | $17.69M 10-Q · filed 2020-11-03 | $33.02M derived: sum of 2 quarters · filed 2021-08-19 | $50.32M derived: sum of 3 quarters · filed 2021-08-19 | $69.94M derived: sum of 4 quarters · filed 2021-08-19 |
| 2019-06-30 | $15.34M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-19 | $32.63M derived: sum of 2 quarters · filed 2021-08-19 | $52.25M derived: sum of 3 quarters · filed 2021-08-19 | $69.55M 10-K · filed 2021-08-19 |
| 2019-03-31 | $17.30M 10-Q · filed 2020-05-05 | $36.91M derived: sum of 2 quarters · filed 2020-05-05 | $54.21M 10-Q · filed 2020-05-05 | $68.81M derived: sum of 4 quarters · filed 2020-08-18 |
| 2018-12-31 | $19.62M 10-Q · filed 2020-01-28 | $36.92M 10-Q · filed 2020-01-28 | $51.51M derived: sum of 3 quarters · filed 2020-08-18 | $66.53M derived: sum of 4 quarters · filed 2020-08-18 |
| 2018-09-30 | $17.30M 10-Q · filed 2019-10-30 | $31.89M derived: sum of 2 quarters · filed 2020-08-18 | $46.92M derived: sum of 3 quarters · filed 2020-08-18 | $61.56M derived: sum of 4 quarters · filed 2020-08-18 |
| 2018-06-30 | $14.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-18 | $29.62M derived: sum of 2 quarters · filed 2020-08-18 | $44.26M derived: sum of 3 quarters · filed 2020-08-18 | $59.84M 10-K · filed 2020-08-18 |
| 2018-03-31 | $15.02M 10-Q · filed 2019-05-01 | $29.67M derived: sum of 2 quarters · filed 2019-05-01 | $45.25M 10-Q · filed 2019-05-01 | $61.47M derived: sum of 4 quarters · filed 2019-08-14 |
| 2017-12-31 | $14.64M 10-Q · filed 2019-02-04 | $30.22M 10-Q · filed 2019-02-04 | $46.45M derived: sum of 3 quarters · filed 2019-08-14 | $60.16M derived: sum of 4 quarters · filed 2019-08-14 |
| 2017-09-30 | $15.58M 10-Q · filed 2018-11-01 | $31.81M derived: sum of 2 quarters · filed 2019-08-14 | $45.52M derived: sum of 3 quarters · filed 2019-08-14 | $62.72M derived: sum of 4 quarters · filed 2019-08-14 |
| 2017-06-30 | $16.23M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-14 | $29.93M derived: sum of 2 quarters · filed 2019-08-14 | $47.14M derived: sum of 3 quarters · filed 2019-08-14 | $64.92M 10-K · filed 2019-08-14 |
| 2017-03-31 | $13.71M 10-Q · filed 2018-05-09 | $30.91M derived: sum of 2 quarters · filed 2018-05-09 | $48.70M 10-Q · filed 2018-05-09 | $62.65M derived: sum of 4 quarters · filed 2018-08-15 |
| 2016-12-31 | $17.21M 10-Q · filed 2018-02-07 | $34.99M 10-Q · filed 2018-02-07 | $48.94M derived: sum of 3 quarters · filed 2018-08-15 | $63.57M derived: sum of 4 quarters · filed 2018-08-15 |
| 2016-09-30 | $17.78M 10-Q · filed 2017-11-08 | $31.74M derived: sum of 2 quarters · filed 2018-08-15 | $46.37M derived: sum of 3 quarters · filed 2018-08-15 | $60.19M derived: sum of 4 quarters · filed 2018-08-15 |
| 2016-06-30 | $13.96M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-15 | $28.59M derived: sum of 2 quarters · filed 2018-08-15 | $42.41M derived: sum of 3 quarters · filed 2018-08-15 | $56.07M 10-K · filed 2018-08-15 |
| 2016-03-31 | $14.63M 10-Q · filed 2017-05-10 | $28.45M derived: sum of 2 quarters · filed 2017-05-10 | $42.12M 10-Q · filed 2017-05-10 | $56.90M derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-12-31 | $13.82M 10-Q · filed 2017-02-08 | $27.49M 10-Q · filed 2017-02-08 | $42.27M derived: sum of 3 quarters · filed 2017-09-07 | $56.75M derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-09-30 | $13.66M 10-Q · filed 2016-12-12 | $28.44M derived: sum of 2 quarters · filed 2017-09-07 | $42.92M derived: sum of 3 quarters · filed 2017-09-07 | $57.40M derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-06-30 | $14.78M derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-09-07 | $29.26M derived: sum of 2 quarters · filed 2017-09-07 | $43.74M derived: sum of 3 quarters · filed 2017-09-07 | $57.35M 10-K · filed 2017-09-07 |
| 2015-03-31 | $14.48M 10-Q/A · filed 2016-07-19 | $28.96M derived: sum of 2 quarters · filed 2016-07-19 | $42.57M 10-Q/A · filed 2016-07-19 | $57.92M derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-12-31 | $14.48M 10-Q · filed 2016-02-09 | $28.09M 10-Q · filed 2016-02-09 | $43.44M derived: sum of 3 quarters · filed 2016-12-12 | $58.81M derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-09-30 | $13.62M 10-Q · filed 2015-11-04 | $28.96M derived: sum of 2 quarters · filed 2016-12-12 | $44.34M derived: sum of 3 quarters · filed 2016-12-12 | $57.37M derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-06-30 | $15.34M derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-12 | $30.72M derived: sum of 2 quarters · filed 2016-12-12 | $43.75M derived: sum of 3 quarters · filed 2016-12-12 | $56.80M 10-K · filed 2016-12-12 |
| 2014-03-31 | $15.38M 10-Q · filed 2015-05-06 | $28.41M derived: sum of 2 quarters · filed 2015-05-06 | $41.46M 10-Q · filed 2015-05-06 | |
| 2013-12-31 | $13.03M 10-Q · filed 2015-02-04 | $26.08M 10-Q · filed 2015-02-04 | ||
| 2013-09-30 | $13.05M 10-Q · filed 2014-11-06 | |||
| 2013-06-30 | $57.73M 10-K · filed 2015-09-01 | |||
| 2012-06-30 | $28.72M 10-K · filed 2014-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |